I found this interesting, not so much for the technology discussion, which I think was overselling to say the least, but from the business perspective vis a vi positioning against Libre, collaborations with other device manufacturers and Walgreens as well as keeping the company independent.
The transition to the Philippines has been rough, but this was a great piece to hear. Thank you for posting. I know less than nothing about stocks but asked my advisor to invest in Dexcom because I have loved their ethics. It has paid off!